These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18438810)

  • 1. Chronic hepatitis C genotype 2 or 3 short treatment.
    Moreno-Otero R; Trapero M; Moreno-Monteagudo JA
    Hepatology; 2008 May; 47(5):1796. PubMed ID: 18438810
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic hepatitis C with pegylated alpha-interferons].
    Niederau C
    Dtsch Med Wochenschr; 2002 Mar; 127(11):563-6. PubMed ID: 11894177
    [No Abstract]   [Full Text] [Related]  

  • 3. Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C.
    Koksal I
    J Gastroenterol Hepatol; 2006 Mar; 21(3):491-4. PubMed ID: 16638088
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic genotype 4 hepatitis C.
    Schafer DF
    Hepatology; 2008 May; 47(5):1791-2; author reply 1793-4. PubMed ID: 18395844
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of ribavirin in patients with chronic HCV genotype 1: when enough is really enough.
    Shiffman ML; Rustgi VK
    Gastroenterology; 2006 Oct; 131(4):1339-41. PubMed ID: 17030201
    [No Abstract]   [Full Text] [Related]  

  • 6. Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues.
    Yu ML; Dai CY; Huang JF; Hsieh MY; Chuang WL
    Hepatology; 2008 May; 47(5):1792-3; author reply 1793-4. PubMed ID: 18435463
    [No Abstract]   [Full Text] [Related]  

  • 7. No role of the -2518 promoter polymorphism of monocyte chemotactic protein-1 in chronic hepatitis C.
    Bonkovsky HL; Salek J
    Gastroenterology; 2005 Oct; 129(4):1361-2. PubMed ID: 16230097
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of chronic hepatitis C].
    Fehér J; Lengyel G
    Orv Hetil; 2004 May; 145(20):1065-7. PubMed ID: 15202329
    [No Abstract]   [Full Text] [Related]  

  • 9. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
    Gholam PM
    N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15570682
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interferons alpha in the treatment of chronic HCV infections].
    Halota W; Pawłowska M; Andrejczyn M
    Przegl Epidemiol; 2004; 58(3):405-11. PubMed ID: 15730004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible herbal treatment for C4HCV patients who are not suitable for interferon based treatment.
    Canepa J
    Saudi Med J; 2004 Nov; 25(11):1778; author reply 1778. PubMed ID: 15573236
    [No Abstract]   [Full Text] [Related]  

  • 12. Peginterferon and ribavirin for hepatitis C.
    Abramowicz M
    N Engl J Med; 2007 Mar; 356(12):1270-1; author reply 1271. PubMed ID: 17378100
    [No Abstract]   [Full Text] [Related]  

  • 13. Peginterferon and ribavirin for hepatitis C.
    Duggan AE; Duggan JM
    N Engl J Med; 2007 Mar; 356(12):1269; author reply 1271. PubMed ID: 17377169
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients.
    Chung WJ
    Clin Mol Hepatol; 2012 Sep; 18(3):268-71. PubMed ID: 23091806
    [No Abstract]   [Full Text] [Related]  

  • 15. A success story with chronic hepatitis C.
    Weekley D; Yuen JC
    J Ark Med Soc; 2005 Dec; 102(6):158-9. PubMed ID: 16381402
    [No Abstract]   [Full Text] [Related]  

  • 16. Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C?
    Floreani A; Minola E; Carderi I; Ferrara F; Rizzotto ER; Baldo V
    J Am Geriatr Soc; 2006 Mar; 54(3):549-50. PubMed ID: 16551333
    [No Abstract]   [Full Text] [Related]  

  • 17. Into the light: strategies for battling hepatitis C.
    Bacon BR; McHutchison JG
    Am J Manag Care; 2007 Dec; 13 Suppl 12():S319-26. PubMed ID: 18095780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing treatment regimens in hepatitis C.
    Darling JM; Fried MW
    Clin Liver Dis; 2006 Nov; 10(4):835-50. PubMed ID: 17164120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response-guided therapy: optimizing treatment now and in the future.
    Marcellin P; Rizzetto M
    Antivir Ther; 2008; 13 Suppl 1():1-2. PubMed ID: 18432156
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trial: individualized treatment duration for hepatitis C virus genotype 1 with peginterferon-alpha 2a plus ribavirin.
    Tang KH; Herrmann E; Pachiadakis I; Paulon E; Tatman N; Zeuzem S; Naoumov NV
    Aliment Pharmacol Ther; 2008 May; 27(9):810-9. PubMed ID: 18221408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.